SAN DIEGO, Jan. 25 /PRNewswire-FirstCall/ -- Biosite(R) Incorporated
(Nasdaq: BSTE) today reported Tom Watlington, executive vice president and
chief operating officer, will leave the Company by the end of the first
quarter of 2006 to assume an executive operating role at several portfolio
companies of Sanderling Ventures. Watlington, who joined Biosite in 1996,
just prior to the Company's initial public offering, led commercialization of
a string of new products, including the Triage(R) BNP Test, which changed the
practice of heart failure diagnosis and enabled Biosite to become the leader
in cardiovascular in vitro diagnostic testing in 2004.
"Tom played a significant role in transitioning Biosite from a drug
testing company to a market leader in rapid diagnosis for a number of critical
diseases," said Kim Blickenstaff, Biosite's chairman and chief executive
officer. "He will be missed, but leaves in place an experienced, capable and
enthusiastic senior management group that is focused on the success of our
existing and potential products. We thank Tom for his contributions and wish
him the very best."
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage rapid diagnostics are used in approximately 50 percent of
U.S. hospitals and in over 50 international markets. Information on Biosite
can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, VP, Corporate & Investor
Relations, +1-858-805-2820, npadilla@biosite.com, or Media,
Nicole Beckstrand, Public Relations Manager, +1-858-805-2803,
nbeckstrand@biosite.com, both of Biosite Incorporated
|
